Med Ed 101
DECEMBER 22, 2024
I’ve put together an approximately 20-minute video on the BCMTMS exam and what you can expect for 2025. General information on the 2025 BCMTMS Exam Who writes the exam? – National Board of Medication Therapy Management Eligibility ASK EMPLOYER IF THEY WILL HELP PURCHASE STUDY MATERIALS AND TEST COSTS!!!! About The BCMTMS Exam Content Domains […] The post 2025 BCMTMS Exam – How To Prepare?
Pharmacy Joe
DECEMBER 22, 2024
In this episode, Ill discuss the IV vs nebulized route for tranexamic acid to treat hemoptysis. Episode 985: Is the IV or Nebulized Route Better When Giving Tranexamic Acid for Hemoptysis? Subscribe on iTunes , Android , or Stitcher In the treatment of hemoptysis, tranexamic acid has been given via the IV route and topically via nebulization. These two routes of administration were compared in a randomized controlled trial for the first time recently and the results were published in the journal
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
DECEMBER 22, 2024
Proposed reforms to the regulations for PBMs were dropped from the US Congress' end-of-year bill to provide funding to the federal government
Pharmacy Times
DECEMBER 22, 2024
Clinical trials will seek to evaluate the immunogenicity and safety of the LBT-SA7 vaccine.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
pharmaphorum
DECEMBER 22, 2024
Ionis Pharma's Tryngolza (olezarsen) has become the first FDA-approved drug therapy for adults with rare disease familial chylomicronaemia syndrome
Pharmacy Times
DECEMBER 22, 2024
VGT-1849A could reduce JAK2 activity, lessening the disease burden faced by individuals with PV while providing a favorable safety profile.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
PharmaTech
DECEMBER 22, 2024
Carrier-based formulations for dry powder inhalers are carefully designed to transport extremely small particles into the lungs. Jet milling can be used to micronize these particles, with both high and low shear mixing processes used to formulate mixtures capable of carrying the fine API particles into the deep lung.
pharmaphorum
DECEMBER 22, 2024
Lilly's Zepbound has become the first drug approved by the FDA for obese patients with obstructive sleep apnoea, which affects millions in the US
Express Pharma
DECEMBER 22, 2024
A recent study carried out by researchers in Burkina Faso and the UK, and published in The Lancet Infectious Diseases, has shown that the first blood-stage malaria vaccine, RH5.1/Matrix-M, is safe, effective, and highly immunogenic. This double-blind, randomised, controlled, phase 2b trial, which analysed 361 children between the ages of 5 and 17 months, shows promise and highlights the potential for RH5.1/Matrix-M to be a component within a developing malaria vaccine strategy, says GlobalData.
Expert insights. Personalized for you.
90 
Let's personalize your content